196 related articles for article (PubMed ID: 33708878)
1. Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer.
Bittoni A; Pecci F; Mentrasti G; Crocetti S; Lupi A; Lanese A; Pellei C; Ciotti C; Cantini L; Giampieri R; Lenci E; Giglio E; Bini F; Copparoni C; Meletani T; Baleani MG; Berardi R
Ann Transl Med; 2021 Feb; 9(3):251. PubMed ID: 33708878
[TBL] [Abstract][Full Text] [Related]
2. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
[TBL] [Abstract][Full Text] [Related]
3. Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer.
Zhang K; Hua YQ; Wang D; Chen LY; Wu CJ; Chen Z; Liu LM; Chen H
J Transl Med; 2019 Jan; 17(1):30. PubMed ID: 30658662
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer.
Matsubara S; Mabuchi S; Takeda Y; Kawahara N; Kobayashi H
PLoS One; 2021; 16(5):e0248871. PubMed ID: 33989285
[TBL] [Abstract][Full Text] [Related]
5. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
[TBL] [Abstract][Full Text] [Related]
6. Systemic Immune-inflammation Index is the Best Prognostic Factor in Patients with Advanced Stage Adenocarcinoma of the Lung Treated with Pemetrexed.
Bilgetekin I; Basal FB
J Coll Physicians Surg Pak; 2020 Sep; 30(9):933-939. PubMed ID: 33036677
[TBL] [Abstract][Full Text] [Related]
7. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer.
Murthy P; Zenati MS; Al Abbas AI; Rieser CJ; Bahary N; Lotze MT; Zeh HJ; Zureikat AH; Boone BA
Ann Surg Oncol; 2020 Mar; 27(3):898-906. PubMed ID: 31792715
[TBL] [Abstract][Full Text] [Related]
9. The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease.
Ren B; Chen X; Lei P; Hou L; Wang H; Zhou Y; Ren L; Fan H; Wang Z; Yuan J
Front Immunol; 2021; 12():691364. PubMed ID: 34248983
[TBL] [Abstract][Full Text] [Related]
10. Systemic Immune-Inflammation Index and Changes of Neutrophil-Lymphocyte Ratio as Prognostic Biomarkers for Patients With Pancreatic Cancer Treated With Immune Checkpoint Blockade.
Shang J; Han X; Zha H; Tao H; Li X; Yuan F; Chen G; Wang L; Ma J; Hu Y
Front Oncol; 2021; 11():585271. PubMed ID: 33718140
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer.
Berardi R; Santoni M; Rinaldi S; Bower M; Tiberi M; Morgese F; Caramanti M; Savini A; Ferrini C; Torniai M; Fiordoliva I; Newsom-Davis T
Ann Transl Med; 2019 Oct; 7(20):572. PubMed ID: 31807553
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients.
Xiao Y; Chen W; Xie Z; Shao Z; Xie H; Qin G; Zhao N
BMC Cancer; 2017 Jan; 17(1):25. PubMed ID: 28056913
[TBL] [Abstract][Full Text] [Related]
13. Prognostic efficacy of the combination of the pretreatment systemic Immune-Inflammation Index and Epstein-Barr virus DNA status in locally advanced Nasopharyngeal Carcinoma Patients.
Xiong Y; Shi LL; Zhu LS; Ding Q; Ba L; Peng G
J Cancer; 2021; 12(8):2275-2284. PubMed ID: 33758605
[No Abstract] [Full Text] [Related]
14. Prognostic significance of systemic immune-inflammation index and platelet-albumin-bilirubin grade in patients with pancreatic cancer undergoing radical surgery.
Han R; Tian Z; Jiang Y; Guan G; Sun X; Yu Y; Zhang L; Zhou J; Jing X
Gland Surg; 2022 Mar; 11(3):576-587. PubMed ID: 35402206
[TBL] [Abstract][Full Text] [Related]
15. Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.
Lolli C; Caffo O; Scarpi E; Aieta M; Conteduca V; Maines F; Bianchi E; Massari F; Veccia A; Chiuri VE; Facchini G; De Giorgi U
Front Pharmacol; 2016; 7():376. PubMed ID: 27790145
[No Abstract] [Full Text] [Related]
16. Systemic immune-inflammation index as a prognostic marker in patients with newly diagnosed metastatic nasopharyngeal carcinoma: a propensity score-matched study.
Lin C; Lin S; Guo QJ; Zong JF; Lu TZ; Lin N; Lin SJ; Pan JJ
Transl Cancer Res; 2019 Sep; 8(5):2089-2098. PubMed ID: 35116958
[TBL] [Abstract][Full Text] [Related]
17. Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: A retrospective study.
Nie D; Gong H; Mao X; Li Z
Gynecol Oncol; 2019 Feb; 152(2):259-264. PubMed ID: 30558974
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of different exosomes' protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy.
Giampieri R; Piva F; Occhipinti G; Bittoni A; Righetti A; Pagliaretta S; Murrone A; Bianchi F; Amantini C; Giulietti M; Ricci G; Principato G; Santoni G; Berardi R; Cascinu S
PLoS One; 2019; 14(5):e0215990. PubMed ID: 31048929
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic cancer: a meta-analysis of 2,365 patients.
Shui Y; Li M; Su J; Chen M; Gu X; Guo W
Aging (Albany NY); 2021 Aug; 13(16):20585-20597. PubMed ID: 34435973
[TBL] [Abstract][Full Text] [Related]
20. Systemic inflammation is associated with inferior disease control and survival in stage III non-small cell lung cancer.
Keit E; Coutu B; Zhen W; Zhang C; Lin C; Bennion N; Ganti AK; Ernani V; Baine M
Ann Transl Med; 2021 Feb; 9(3):227. PubMed ID: 33708854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
